Runzi Yang

Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Long-term clinical course and recurrence pattern of orbital Kimura's disease: a retrospective case series.

Long-term clinical course and recurrence pattern of orbital Kimura's disease: a retrospective case series.

Journal: BMC ophthalmology
Published: March 10, 2026

Clinical prognostic characteristics of ocular mucoepidermoid carcinoma: a retrospective study.

Clinical prognostic characteristics of ocular mucoepidermoid carcinoma: a retrospective study.

Journal: Frontiers in oncology
Published: October 08, 2025

Single-cell atlas of B cell heterogeneity in lacrimal IgG4-related disorders: Unraveling the transition from inflammatory exhaustion to clonal malignancy.

Single-cell atlas of B cell heterogeneity in lacrimal IgG4-related disorders: Unraveling the transition from inflammatory exhaustion to clonal malignancy.

Journal: The FEBS journal
Published: October 01, 2025

Urinary metal mixtures and cataract: Findings from a U.S. population-based study and network pharmacology analysis.

Urinary metal mixtures and cataract: Findings from a U.S. population-based study and network pharmacology analysis.

Journal: Toxicology letters
Published: January 15, 2025

Development and evaluation of a quality-of-life questionnaire for patients with orbital malignant tumours.

Development and evaluation of a quality-of-life questionnaire for patients with orbital malignant tumours.

Journal: BMJ open ophthalmology
Published: July 29, 2024

Orbital Oncocytic Carcinoma: A Comprehensive Case Series and Literature Review.

Orbital Oncocytic Carcinoma: A Comprehensive Case Series and Literature Review.

Journal: Ophthalmic plastic and reconstructive surgery
Published: July 19, 2024

Sebaceous hyperplasia of the eyelid: A comprehensive case report and literature review.

Sebaceous hyperplasia of the eyelid: A comprehensive case report and literature review.

Journal: Heliyon
Published: January 06, 2024

Efficacy and safety of anlotinib as a third-line treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials.

Efficacy and safety of anlotinib as a third-line treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials.

Journal: Oncology letters
Published: March 29, 2022
Showing 1-8 of 8

Last Updated: 09/26/2026